DCGO.NASDAQDocgo INC

Form 4: DocGo CEO Lee Bienstock Receives Stock Grants in Lieu of Cash Incentive

Sentiment:

SEC Form 4 Filing


DocGo's CEO, Lee Bienstock, received 218,579 restricted stock units (RSUs) in lieu of cash incentive payments, according to a recent SEC filing.

Summary

  • An SEC Form 4 filing reveals that Lee Bienstock, CEO of DocGo Inc., received 218,579 restricted stock units (RSUs) on March 15, 2024, in lieu of cash incentive payments.
  • These RSUs will vest in six equal quarterly installments starting April 1, 2024.
  • Each RSU represents the right to receive one share of DocGo's common stock upon vesting, subject to the terms of the company's 2021 Stock Incentive Plan.
  • Following the transaction, Bienstock beneficially owns 1,199,592 shares of DocGo common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The RSU grant is a standard practice, aligning CEO incentives with shareholder value. The vesting schedule promotes long-term commitment.

Positives

  • The grant of RSUs aligns the CEO's interests with those of the shareholders, incentivizing him to improve the company's performance.
  • The vesting schedule encourages long-term commitment from the CEO.

Future Outlook

The CEO's compensation is now more closely tied to the company's stock performance, potentially influencing future strategic decisions.

Industry Context

Stock-based compensation is a common practice in the industry to align management's interests with those of shareholders.

Comparison to Industry Standards

  • Comparing DocGo's executive compensation structure to similar companies in the healthcare technology sector would provide a benchmark for assessing the appropriateness of the RSU grants.
  • Companies like Teladoc Health and Amwell also utilize stock-based compensation as part of their executive pay packages.
  • Analyzing the vesting schedules and the proportion of stock-based compensation relative to cash compensation would offer further insights.

Stakeholder Impact

  • Shareholders may view the RSU grant positively as it aligns the CEO's interests with the company's long-term success.
  • Employees may see this as a sign of confidence in the company's future.

Key Dates

DateDescription
2021Issuer's 2021 Stock Incentive Plan
May 12, 2023Date for annual vesting installments for 121,951 RSUs
December 12, 2023Date for annual vesting installments for 675,690 RSUs
March 15, 2024Transaction date for the grant of 218,579 RSUs
March 18, 2024Date of signature for the SEC filing
April 1, 2024Start date for quarterly vesting installments of the 218,579 RSUs
March 28, 2024Date for vesting installments for 110,140 RSUs
March 28, 2025Date for vesting installments for 110,140 RSUs
March 28, 2026Date for vesting installments for 110,140 RSUs

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.